关于 "VEGFR" 的结果7 个结果

筛选:Enzymes×
  • GP22650 structure
    VEGFR2 Human

    Vascular Endothelial Growth Factor Receptor-2 Human Recombinant

  • GP22651 structure
    VEGFR2 Fc Human

    Vascular Endothelial Growth Factor Receptor-2 Fc Chimera Human Recombinant

  • GP22652 structure
    VEGFR2 Human, His

    Vascular Endothelial Growth Factor receptor-2 Human Recombinant, His Tag

  • GC62145 structure
    Chiauranib
    CAS: 1256349-48-0

    Chiauranib (CS2164) selectively inhibits multiple kinase targets aurora B kinase (AURKB), colony-stimulating factor 1 receptor (CSF1R), and vascular endothelial growth factor receptor (VEGFR)/platelet-derived growth factor receptor (PDGFR)/c-Kit , thereby inhibiting the rapid proliferation of tumor cells, enhancing the antitumor immunity, and inhibiting tumor angiogenesis, to achieve the anti-tumor efficacy.

  • GC69068 structure
    ENMD-2076 Tartrate
    CAS: 1453868-32-0

    ENMD-2076 Tartrate 是多靶点激酶抑制剂,抑制 Aurora A,Flt3,KDR/VEGFR2,Flt4/VEGFR3,FGFR1,FGFR2,Src,PDGFRα 的IC50 值分别为1.86,14,58.2,15.9,92.7,70.8,20.2 and 56.4 nM。

  • GC69633 structure
    Orobol
    CAS: 480-23-9

    Orobol 是一种主要的大豆异黄酮,具有多种药理活性,包括抗皮肤老化和抗肥胖作用。Orobol 抑制 CK1ε、VEGFR2、MAP4K5、MNK1、MUSK、TOPK 和 TNIK (IC50=1.24-4.45 μM)。Orobol 还抑制 PI3K 亚型 (对于 PI3K α/β/γ/K/δ,IC50=3.46-5.27μM)。

  • GC70030 structure
    Tinengotinib
    CAS: 2230490-29-4

    Tinengotinib 是一种或多种蛋白激酶的调节剂,例如 Aurora 激酶和 VEGFR 激酶。Tinengotinib 具有研究这些激酶异常介导的疾病的潜力,尤其是癌症相关疾病 (摘自专利 WO2018108079A1)。